Javier Alonso

4.1k total citations
75 papers, 1.8k citations indexed

About

Javier Alonso is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Javier Alonso has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Javier Alonso's work include Sarcoma Diagnosis and Treatment (12 papers), Cancer-related Molecular Pathways (11 papers) and Ocular Oncology and Treatments (11 papers). Javier Alonso is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Cancer-related Molecular Pathways (11 papers) and Ocular Oncology and Treatments (11 papers). Javier Alonso collaborates with scholars based in Spain, France and Germany. Javier Alonso's co-authors include Laura González‐González, Ángel Pestaña, Florencia Cidre‐Aranaz, Purificación García‐Miguel, Itziar Palacios, Santos Casado, Antonio López‐Farré, Lourdes Sánchez de Miguel, Enzo Lalli and Jaime Carrillo and has published in prestigious journals such as Circulation, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Javier Alonso

72 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Alonso Spain 26 913 490 403 305 213 75 1.8k
Linnea Chap United States 13 662 0.7× 1.0k 2.1× 367 0.9× 417 1.4× 131 0.6× 28 1.7k
Raymond M. Shaheen United States 15 1.3k 1.5× 753 1.5× 363 0.9× 693 2.3× 74 0.3× 20 2.0k
Zhenhua Zhai China 14 685 0.8× 484 1.0× 251 0.6× 356 1.2× 93 0.4× 22 1.4k
Randall Schreck United States 9 1.5k 1.7× 686 1.4× 318 0.8× 469 1.5× 31 0.1× 13 2.3k
Gisele Sarosy United States 21 654 0.7× 810 1.7× 225 0.6× 231 0.8× 108 0.5× 38 1.7k
Jacques Gaudreault United States 17 1.2k 1.3× 1.4k 2.8× 1.2k 3.0× 467 1.5× 94 0.4× 36 3.2k
Frauke Bentzien United States 10 821 0.9× 665 1.4× 522 1.3× 298 1.0× 43 0.2× 12 2.1k
Jeanine M.L. Roodhart Netherlands 22 1.0k 1.1× 1.3k 2.6× 399 1.0× 646 2.1× 41 0.2× 85 2.3k
Armelle Logié United Kingdom 19 962 1.1× 442 0.9× 202 0.5× 433 1.4× 39 0.2× 33 1.6k
T. Annie T. Fong United States 7 1.3k 1.4× 523 1.1× 231 0.6× 555 1.8× 37 0.2× 10 1.8k

Countries citing papers authored by Javier Alonso

Since Specialization
Citations

This map shows the geographic impact of Javier Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Alonso more than expected).

Fields of papers citing papers by Javier Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Alonso. The network helps show where Javier Alonso may publish in the future.

Co-authorship network of co-authors of Javier Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Alonso. A scholar is included among the top collaborators of Javier Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Alonso. Javier Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mera, Raquel M. Melero-Fernández de, et al.. (2025). Targeted inactivation of EWSR1 : : FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter. Cancer Gene Therapy. 32(4). 437–449. 2 indexed citations
2.
Delgado‐Bellido, Daniel, Ana Teresa Amaral, Shunya Ohmura, et al.. (2025). EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism. Oncogene. 44(38). 3537–3552.
3.
García‐García, Laura, Laura González‐González, Cristina Robledo, et al.. (2023). CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells. International Journal of Molecular Sciences. 24(14). 11774–11774. 8 indexed citations
4.
Díaz‐Martín, Juan, Alfonso Bolado‐Carrancio, Marina Esteban‐Medina, et al.. (2022). Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell–Matrix Interactions. International Journal of Molecular Sciences. 23(15). 8657–8657. 7 indexed citations
5.
Mera, Raquel M. Melero-Fernández de, Matías Morin, Laura García‐García, et al.. (2021). Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma. Cancers. 13(15). 3783–3783. 20 indexed citations
6.
Romero‐Pérez, Laura, Ana Teresa Amaral, David Marcilla, et al.. (2019). Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1 ‐opposing gene signature and associate with disease progression in Ewing sarcoma. The Journal of Pathology. 250(4). 374–386. 21 indexed citations
7.
Robledo, Cristina, Gema Gómez‐Mariano, Sara Monzón, et al.. (2019). Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype–phenotype relationships. Journal of Human Genetics. 65(2). 165–174. 22 indexed citations
8.
López‐Martín, Estrella, et al.. (2018). SpainUDP: The Spanish Undiagnosed Rare Diseases Program. International Journal of Environmental Research and Public Health. 15(8). 1746–1746. 14 indexed citations
9.
Pita, Guillermo, Ana Patiño‐García, Javier Alonso, et al.. (2017). Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer. Pharmacogenetics and Genomics. 27(12). 445–453. 22 indexed citations
10.
Cidre‐Aranaz, Florencia, Thomas G. P. Grünewald, Didier Surdez, et al.. (2016). EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma. Oncogene. 36(6). 766–776. 25 indexed citations
11.
Alonso, Javier, et al.. (2015). Potential Factors Governing Extracellular Matrix Production by Mesangial Cells: Their Relevance for the Pathogenesis of IgA Nephropathy1. Contributions to nephrology. 111. 45–54. 3 indexed citations
12.
Lara, Beatriz, María Teresa Martínez, Ignacio Blanco, et al.. (2014). Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. Respiratory Research. 15(1). 125–125. 27 indexed citations
13.
Gómez-Cabello, Daniel, Sergio Callejas, Alberto Benguría, et al.. (2010). Regulation of the MicroRNA Processor DGCR8 by the Tumor Suppressor ING1. Cancer Research. 70(5). 1866–1874. 30 indexed citations
14.
Lalli, Enzo & Javier Alonso. (2010). Targeting DAX-1 in embryonic stem cells and cancer. Expert Opinion on Therapeutic Targets. 14(2). 169–177. 24 indexed citations
15.
Carrillo, Jaime, Noelia Agrá, Noemí Fernández, Ángel Pestaña, & Javier Alonso. (2009). Devazepide, a nonpeptide antagonist of CCK receptors, induces apoptosis and inhibits Ewing tumor growth. Anti-Cancer Drugs. 20(7). 527–533. 13 indexed citations
16.
Valverde, José Ramón, Javier Alonso, Itziar Palacios, & Ángel Pestaña. (2005). RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genetics. 6(1). 53–53. 110 indexed citations
17.
18.
Alonso, Javier, Purificación García‐Miguel, Marta Mendiola, et al.. (2001). Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications. Human Mutation. 17(5). 412–422. 58 indexed citations
19.
Miguel, Lourdes Sánchez de, Javier Alonso, Fernando González-Fernández, et al.. (1999). Evidence That an Endothelial Cytosolic Protein Binds to the 3′-Untranslated Region of Endothelial Nitric Oxide Synthase mRNA. Journal of Vascular Research. 36(3). 201–208. 27 indexed citations
20.
Alonso, Javier, Marta Gómez-Chiarri, Alberto Ortíz, et al.. (1996). Glomerular up-regulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. Kidney International. 50(3). 908–919. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linnea Chap Breakdown of academic impact, for papers by Raymond M. Shaheen Breakdown of academic impact, for papers by Zhenhua Zhai Breakdown of academic impact, for papers by Randall Schreck Breakdown of academic impact, for papers by Gisele Sarosy Breakdown of academic impact, for papers by Jacques Gaudreault Breakdown of academic impact, for papers by Frauke Bentzien Breakdown of academic impact, for papers by Jeanine M.L. Roodhart Breakdown of academic impact, for papers by Armelle Logié Breakdown of academic impact, for papers by T. Annie T. Fong
Rankless by CCL
2026